Xueshan Zhao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Xueshan Zhao has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
Chengcheng Li
Lanzhou University First Affiliated Hospital
1 shared publication- Chengcheng Li
Modern Chinese Literature, Department of Chinese Language and Literature, Peking University, Beijing 100871, China
1 shared publication Hongtao Luo
Institute of Modern Physics Chinese Academy of Sciences
1 shared publication- Kehu Yang
Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University; Lanzhou, Gansu China
1 shared publication Lina Wang
Lanzhou University First Affiliated Hospital
1 shared publication- Lina Wang
The First School of Clinical Medicine, Lanzhou Uni
1 shared publication
Latest Publications
- Open Access
- 10 August 2021
- Published by Springer Nature in Research Square
Silencing of lncRNA H19 Enhances the Sensitivity to X-rays and Carbon-Ions Through the miR-130a-3p /WNK3 Signal Axis in Non-Small-Cell Lung Cancer Cells
Background: LncRNA H19 was believed to act as an oncogene in various types of tumors and was considered to be a therapeutic target and diagnosis marker. However, the role of lncRNA H19 in regulating the radiosensitivity of non-small cell lung cancer (NSCLC) cells was unknown. However, the effects of lncRNA H19 on radiosensitivity of NSCLC were not clear. Methods: The expression profiles of lncRNAs were explored via transcriptome sequencing in NSCLC. The CCK-8, EDU, and clonogenicity survival assay were conducted to explore the proliferation and radiosensitivity in NSCLC cells. Results: Expression patterns of lncRNAs revealed that compared with A549 cells, lncRNA H19 was upregulated in radioresistant NSCLC(A549-R11) cells. Knockdown experiments revealed that lncRNA H19 enhanced the radiation sensitivity of both A549 and H460 cancer cell lines to X-rays and carbon ion irradiation. Mechanistically, lncRNA H19 upregulated With-No-Lysine Kinase 3 (WNK3) expression via serving as a sponge of miR-130a-3p and promoted the resistance of NSCLC cells to both X-rays and carbon ion irradiation. Conclusion: Knockdown of lncRNA H19 promoted the radiation sensitivity of NSCLC cells to X-rays and carbon ion irradiation. Hence, lncRNA H19 might function as a potential therapeutic target which enhance the anti-tumor effects of radiotherapy in NSCLC.
- 10 August 2021
- Published by Springer Nature in Research Square
Open AccessSilencing of lncRNA H19 Enhances the Sensitivity to X-rays and Carbon-Ions Through the miR-130a-3p /WNK3 Signal Axis in Non-Small-Cell Lung Cancer Cells
Background: LncRNA H19 was believed to act as an oncogene in various types of tumors and was considered to be a therapeutic target and diagnosis marker. However, the role of lncRNA H19 in regulating the radiosensitivity of non-small cell lung cancer (NSCLC) cells was unknown. However, the effects of lncRNA H19 on radiosensitivity of NSCLC were not clear. Methods: The expression profiles of lncRNAs were explored via transcriptome sequencing in NSCLC. The CCK-8, EDU, and clonogenicity survival assay were conducted to explore the proliferation and radiosensitivity in NSCLC cells. Results: Expression patterns of lncRNAs revealed that compared with A549 cells, lncRNA H19 was upregulated in radioresistant NSCLC(A549-R11) cells. Knockdown experiments revealed that lncRNA H19 enhanced the radiation sensitivity of both A549 and H460 cancer cell lines to X-rays and carbon ion irradiation. Mechanistically, lncRNA H19 upregulated With-No-Lysine Kinase 3 (WNK3) expression via serving as a sponge of miR-130a-3p and promoted the resistance of NSCLC cells to both X-rays and carbon ion irradiation. Conclusion: Knockdown of lncRNA H19 promoted the radiation sensitivity of NSCLC cells to X-rays and carbon ion irradiation. Hence, lncRNA H19 might function as a potential therapeutic target which enhance the anti-tumor effects of radiotherapy in NSCLC.
- Open Access
- 30 April 2020
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Effects of DRP1 on tumor metastasis: a systematic review
INPLASY202040208 Effects of DRP1 on tumor metastasis: a systematic review Keywords: DRP1; metastasis; systematic review. Download PDF – 202040208
- 30 April 2020
- Published by International Platform of Registered Systematic Review and Meta-analysis Protocols (INPLASY)
Open AccessEffects of DRP1 on tumor metastasis: a systematic review
INPLASY202040208 Effects of DRP1 on tumor metastasis: a systematic review Keywords: DRP1; metastasis; systematic review. Download PDF – 202040208